ClinConnect ClinConnect Logo
Search / Trial NCT06183060

Study on the Decision Support System of Difficult Airway Evaluation

Launched by PEKING UNIVERSITY THIRD HOSPITAL · Dec 22, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is focused on improving the way doctors predict and manage difficult airways during surgery, specifically for patients undergoing surgery for cervical spondylosis, which is a condition affecting the neck. The researchers are looking at different physical and imaging signs before surgery to create a reliable system that can alert doctors if a patient may have a difficult airway. This will help ensure that patients receive the best care and have safer surgeries.

To be eligible for this study, patients should be between 18 and 75 years old, generally healthy (classified as ASA I-III), and scheduled for elective surgery that requires general anesthesia and tracheal intubation. Unfortunately, those with specific conditions like cervical spine instability, airway diseases, or incomplete medical imaging cannot participate. If you join the study, you can expect to undergo evaluations that help assess your individual risk for a difficult airway, with the goal of improving surgical outcomes. Your participation will contribute to developing better tools for future patients facing similar surgeries.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • patients of ASA I-III
  • scheduled for elective surgery for cervical spondylosis under general anesthesia with tracheal intubation
  • Exclusion Criteria:
  • patients with cervical spine instability
  • oropharyngeal mass
  • airway disease
  • preoperative imaging data were incomplete
  • refuse to sign informed consent

About Peking University Third Hospital

Peking University Third Hospital is a leading medical institution in China, renowned for its commitment to advanced healthcare, innovative research, and comprehensive clinical services. As a prominent sponsor of clinical trials, the hospital emphasizes the integration of cutting-edge scientific research with patient-centered care to enhance therapeutic outcomes. With a multidisciplinary approach, the institution fosters collaboration among top-tier medical professionals and researchers, striving to contribute to the global medical community through rigorous clinical studies that address pressing health challenges. Its dedication to ethical standards and regulatory compliance ensures the safety and efficacy of new treatments, ultimately aiming to improve patient care and outcomes on both a national and international scale.

Locations

Beijing, Beijing, China

Patients applied

0 patients applied

Trial Officials

Yongzheng Han, M.D.

Study Chair

Peking University Third Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported